» Authors » Joseph R Evans

Joseph R Evans

Explore the profile of Joseph R Evans including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 2383
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Paradis K, Mayo C, Matrosic C, Prisciandaro J, Rosen B, Allen S, et al.
Int J Radiat Oncol Biol Phys . 2025 Mar; PMID: 40068779
Introduction: Reirradiation (reRT) has become increasingly prevalent due to an aging population and advancements in cancer detection and treatment. However, the field is still lacking standardized dosimetric evaluation methods and...
2.
Strong M, Linzey J, Goethe P, Kathawate V, Tudrick L, Lee J, et al.
Am J Clin Oncol . 2025 Jan; PMID: 39838517
Objectives: To determine if piecemeal separation surgery, in conjunction with smaller treatment volumes utilized with spine stereotactic radiation therapy (S-SBRT), increased the risk of adjacent level progression (ALP). Methods: We...
3.
Linzey J, Strong M, Kathawate V, Goethe P, Tudrick L, Lee J, et al.
Oncol Lett . 2024 Nov; 29(1):5. PMID: 39492935
Spinal metastases can be contained in the bone or have epidural spread. Whether the extent of epidural involvement changes tumor response to therapy is unknown. The decision of when to...
4.
McVeigh L, Linzey J, Strong M, Duquette E, Evans J, Szerlip N, et al.
Neurooncol Adv . 2024 Oct; 6(Suppl 3):iii28-iii47. PMID: 39430390
Background: Advances in local and systemic therapies continue to improve overall survival for patients with cancer, increasing the incidence of spine metastases. Up to 15% of patients with solid tumors...
5.
Wenzel D, Schuler A, Smith D, Evans J, Harms K, Pedersen E
JAAD Case Rep . 2024 Oct; 52:112-115. PMID: 39385809
No abstract available.
6.
Elaimy A, El-Derany M, James J, Wang Z, Pearson A, Holcomb E, et al.
JCI Insight . 2024 Sep; 9(21). PMID: 39287988
End-stage liver disease is marked by portal hypertension, systemic elevations in ammonia, and development of hepatocellular carcinoma (HCC). While these clinical consequences of cirrhosis are well described, it remains poorly...
7.
Lu Z, Polan D, Wei L, Aryal M, Fitzpatrick K, Wang C, et al.
J Nucl Med . 2024 Jul; 65(8):1224-1230. PMID: 38960710
Functional liver parenchyma can be damaged from treatment of liver malignancies with Y selective internal radiation therapy (SIRT). Evaluating functional parenchymal changes and developing an absorbed dose (AD)-toxicity model can...
8.
Edwards D, Gharzai L, Wang W, Mayo C, Suresh K, Schipper M, et al.
Head Neck . 2024 Apr; 46(11):2687-2698. PMID: 38680087
Background: Post-treatment surveillance recommendations for oropharyngeal cancer do not vary with p16 status despite the differences in outcomes. The optimal algorithm personalizing follow-up for these patients remains undefined. Here, we...
9.
Das R, Abbott M, Hadley S, Sahai V, Bednar F, Evans J, et al.
Adv Radiat Oncol . 2023 Dec; 8(6):101266. PMID: 38047228
Purpose: Patients with pancreatic cancer undergoing chemoradiation therapy may experience acute and chronic side effects. We conducted an exploratory analysis of patients with locally advanced pancreatic cancer (LAPC) undergoing definitive...
10.
Linzey J, Kathawate V, Strong M, Roche K, Goethe P, Tudrick L, et al.
Cancer Med . 2023 Sep; 12(19):20177-20187. PMID: 37776158
Background: As cancer therapies have improved, spinal metastases are increasingly common. Resulting complications have a significant impact on patient's quality of life. Optimal methods of surveillance and avoidance of neurologic...